Besivance® (besifloxacin) Ophthalmic Suspension 0.6%, is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria:

Aerococcus viridans*
CDC coryneform group G
Corynebacterium pseudodiphtheriticum*
Corynebacterium striatum*
Haemophilus influenzae
Moraxella lacunata*
Moraxella catarrhalis*
Pseudomonas aeruginosa*
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus hominis*
Staphylococcus lugdunensis*
Staphylococcus warneri*
Streptococcus mitis group
Streptococcus oralis
Streptococcus pneumoniae
Streptococcus salivarius*

*Efficacy for this organism was studied in fewer than 10 infections.

Invert closed bottle and shake once before use.

Instill one drop in the affected eye(s) 3 times a day, four to twelve hours apart for 7 days.

Dosage Forms And Strengths

7.5 mL bottle filled with 5 mL of besifloxacin ophthalmic suspension, 0.6%.

Storage And Handling

Besivance® (besifloxacin) Ophthalmic Suspension 0.6%, is supplied as a sterile ophthalmic suspension in a white low density polyethylene (LDPE) bottle with a controlled dropper tip and tan polypropylene cap. Tamper evidence is provided with a shrink band around the cap and neck area of the package.

5 mL in 7.5 mL bottle

NDC 24208-446-05

Storage

Store at 15°- 25°C (59° - 77°F). Protect from Light.

Invert closed bottle and shake once before use.

Manufactured by: Bausch & Lomb Incorporated Tampa, Florida 33637. Revised: 9/2012

Last reviewed on RxList: 10/26/2012
This monograph has been modified to include the generic and brand name in many instances.